Wisderm.com
Open menu
Concerns
Interventions
Latest Research
FAQ
Effect of Hexylresorcinol on Elastic Fibres
Efficacy
Study
Method
Effect
Description
Study Outcomes
4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial
Quantitative PCR
⇧
Sign in to read for free
4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial
Sign in to read for free
4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial
Quantitative PCR
🠩
Sign in to read for free
4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial
Sign in to read for free
4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial
Quantitative PCR
🠩
Sign in to read for free
4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial
Sign in to read for free
A double-blind randomised controlled trial - the gold standard
A human study that doesn't meet the gold standard
A case report or a study conducted on animals, tissues, or cells
Latest Research
4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial (2015)
See study outcomes
Sign in to read for free